Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 6 of 6 publications.

Chang M, Peters B, Ronquest N, Lucas A, Zhang Y, Simpson M, Shelley K. Assessing the budget impact and time savings of introducing nivolumab and hyaluronidase SC to patients receiving nivolumab IV across multiple indications on a US healthcare plan. Poster to be given at the ISPOR 2025; May 14, 2025. Montréal, Canada.

Ronquest N, Zhang Y, Mladsi D. Assessing the impact of the United States (US) Inflation Reduction Act (IRA) regulations on investment incentives for orphan disease drug development. Poster to be given at the ISPOR 2025; May 14, 2025. Montréal, Canada.

Ronquest N, Zhang Y, Paret K, Armstrong S, Mostovoy L, Berggren R. Identifying the value drivers in obesity treatment: a targeted review of weight loss effects on health economic outcomes. Poster presented at the ISPOR Europe 2024; November 17, 2024. Barcelona, Spain. [abstract] Value Health. 2024 Dec; 27(12 Supplement):S148. doi: 10.1016/j.jval.2024.10.752

Zhang Y, Mayorga ME, Ivy J, Hassmiller Lich K, Swann JL. Modeling the impact of nonpharmaceutical interventions on COVID-19 transmission in K-12 schools. MDM Policy Pract. 2022 Dec 3;7(2):238146832. doi: 10.1177/23814683221140866

Zhang Y, Mayorga M, Ivy J, Lich KH, Swann JL. Modeling the impact of non-pharmaceutical interventions on COVID-19 transmission in K-12 schools. Presented at the INFORMS Annual Meeting 2022; October 17, 2022. Indianapolis, IN.

Zhang Y, Johnson K, Yu Z, Fujimoto A, Lich KH, Ivy JS, Keskinocak P, Mayorga M, Swann J. The impact of interventions on COVID-19 transmission in K12 schools in fall 2021. Presented at the 2021 INFORMS Annual Meeting; October 24, 2021. Anaheim, CA.